2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO39] Mini-Oral Session 39　Lung Cancer / Thoracic Cancer 5（Rare tumor）
【E】

Sat. Feb 19, 2022 2:00 PM - 2:50 PM Room 11 (Prince Hall 1, B2F, The Prince Kyoto Takaragaike)

Chair：Koichi Azuma（Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine,Kurume University School of Medicine），Ichiro Kinoshita（Division of Clinical Cancer Genomics）

[MO39-4] An association between p16/MTAP status and the efficacy of cisplatin-plus-pemetrexed or nivolumab treatment of MPM

○Yuki Shinno1, Yukiko Shimoda1, Ken Masuda1, Yuji Matsumoto1, Yusuke Okuma1, Tatsuya Yoshida1,2, Yasushi Goto1, Hidehito Horinouchi1, Noboru Yamamoto1,2, Noriko Motoi3, Yasushi Yatabe4, Yuichiro Ohe1 (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Department of Experimental Therapeutics, National Cancer Center Hospital, 3.Department of Pathology, Saitama Cancer Center, 4.Department of Diagnostic Pathology, National Cancer Center Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password